Cargando…

International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy

Compared with treatment options for early-stage breast cancer, few data exist regarding the optimal use of chemotherapy for metastatic breast cancer (MBC). The choice of using a combination of cytotoxic chemotherapies vs sequential single agents is controversial. At the 6th European Breast Cancer Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardoso, Fatima, Bedard, Philippe L., Winer, Eric P., Pagani, Olivia, Senkus-Konefka, Elzbieta, Fallowfield, Lesley J., Kyriakides, Stella, Costa, Alberto, Cufer, Tanja, Albain, Kathy S.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736293/ https://www.ncbi.nlm.nih.gov/pubmed/19657108 http://dx.doi.org/10.1093/jnci/djp235

Ejemplares similares

International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
por: Pagani, Olivia, et al.
Publicado: (2010)

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004
por: Senkus-Konefka, Elżbieta, et al.
Publicado: (2004)

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic
por: Curigliano, Giuseppe, et al.
Publicado: (2020)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)
por: Cardoso, F., et al.
Publicado: (2014)

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer
por: Aapro, Matti, et al.
Publicado: (2022)

Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer
por: Fallowfield, Lesley
Publicado: (2007)

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology
por: Senkus, Elżbieta
Publicado: (2017)

Biology of Metastasis With Focus on Proteases
por: Cufer, Tanja
Publicado: (2005)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
por: Cufer, Tanja, et al.
Publicado: (2023)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
por: Cardoso, F, et al.
Publicado: (2017)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
por: Cardoso, F., et al.
Publicado: (2017)

A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)
por: Senkus-Konefka, E, et al.
Publicado: (2005)

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
por: Pelicon, Veronika, et al.
Publicado: (2023)

Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance
por: Fallowfield, Lesley, et al.
Publicado: (2021)

Psychosocial controversies in breast cancer
por: Fallowfield, Lesley
Publicado: (2007)

Psychosocial aspects of risk appraisal
por: Fallowfield, Lesley
Publicado: (2008)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Should age impact breast cancer management in young women? Fine tuning of treatment guidelines
por: Suter, Matteo B., et al.
Publicado: (2018)

The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer
por: Harder, Helena, et al.
Publicado: (2020)

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
por: Cardoso, F., et al.
Publicado: (2020)

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development
por: Peiffer, Daniel S., et al.
Publicado: (2020)

Lost but Not Least—Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer
por: Kunc, Michał, et al.
Publicado: (2021)

Are All Societies Ready for Digital Tools? Feasibility Study on the Use of Mobile Application in Polish Early Breast Cancer Patients Treated with Perioperative Chemotherapy
por: Suchodolska, Grażyna, et al.
Publicado: (2023)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

Oral treatment with etoposide in small cell lung cancer – dilemmas and solutions
por: Rezonja, Renata, et al.
Publicado: (2013)

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
por: Omersa, Daniel, et al.
Publicado: (2016)

Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'
por: Fallowfield, Lesley, et al.
Publicado: (2008)

The myth of pulmonary metastasectomy
por: Macbeth, Fergus, et al.
Publicado: (2020)

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study
por: Kunc, Michał, et al.
Publicado: (2020)

Compound nucleus decay: sequential evaporation vs. statistical multifragmentation
por: Carlson, B, et al.
Publicado: (2012)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Reply to ‘Comment on “The myth of pulmonary metastasectomy’”
por: Macbeth, Fergus, et al.
Publicado: (2020)

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial
por: Kurreck, Annika, et al.
Publicado: (2022)

Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival
por: Humar, Mojca, et al.
Publicado: (2017)

PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung
por: Janzic, Urska, et al.
Publicado: (2017)

Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era
por: Mamounas, Eleftherios P., et al.
Publicado: (2018)

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Crew, Katherine D., et al.
Publicado: (2017)

Outcomes of simultaneous vs. sequential pars plana vitrectomy and cataract surgery
por: Moraru, Andreea Dana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3pmv3ehuqkpvb6dctno1bs62ch